Strides Arcolab launches swine flu drug “Starflu”

India head quartered global pharmaceutical company Strides Arcolab Limited (Strides) launched its anti-Swine Flu drug ‘Starflu’ and it’s available in Indian retail stores.

Strides Arcolab’s Starflu is the generic version of H1N1 swine flu drug oseltamivir (Tamiflu) and its available in 75 mg capsules in a strip of 10’s, at a maximum retail price of Rs 460 per strip.

The Strides move is subsequent to the Indian Government’s approval of restricted retail sale of Oseltamivir (Tamiflu) for H1N1 treatment.  This will allow the purchase of Oseltamivir from designated chemists with Schedule X licenses, by those who have doctor prescriptions.

The retail effort for Starflu is being carried out by the Domestic Critical Care Division of Strides. Starflu is being made available in the 480 odd designated chemists/pharmacies with the required schedule X license.

Starflu is manufactured by Strides in its USFDA approved and WHO pre-qualified oral dosage forms manufacturing facility in Bangalore.  Strides has also conducted necessary bioequivalence studies and established bioequivalence of its product with Tamiflu. 

Strides are amongst the few manufacturers who have been selected to supply the generic version of Oseltamivir to Government. 

“Strides has the requisite stocks of Starflu to adequately supply and service the retail demand for this drug”, said Nitin Ghadiyar, President, Strides Arcolab Limited.

Strides has operates its significant presence in Australasia, Africa and India and through a series of strategies is expanding its North American and European growth.

The company has series of joint ventures and front-ended operations in major markets and is a majority stakeholder of Ascent Pharmahealth Limited (APH), an ASX listed  company. The company also collaborates closely with Global Drug Agencies and US PEPFAR and the UNICEF to supply a range of affordable generic pharmaceutical products used in the treatment of HIV, TB and Malaria.

Check out these stories also:

1. Wockhardt launches anti-hypertensive drug Nicardipine injections in USA
2. USFDA gives nod to Glenmark Generics’ 3 abbreviated new drug application
3. Venus Remedies Anti-Cancer drug ‘Gemcitabine’ gets UK MHRA approval
4. Wockhardt gets US FDA nod for generic version of ToprolXL
5. USFDA gives nod for Glenmark Generics’ Norethindrone contraceptive tablets

Custom Search